FNY Managed Accounts’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ICPT
SM
BB
FNY Managed Accounts's ICPT Position: Q4 2017 in Review
FNY Managed Accounts sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2017, closing a stake of 7,200 shares — an estimated $417K sold.
FNY Managed Accounts first reported a position in ICPT in Q3 2015 and held it in 3 quarters. The position peaked at $417K in Q3 2017. 168 funds tracked by Wall St. Rank hold ICPT as of Q4 2017.
- FNY Managed Accounts reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
- FNY Managed Accounts sold 7,200 Intercept Pharmaceuticals, Inc. shares in Q4 2017, an estimated $417K.
- FNY Managed Accounts first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
- FNY Managed Accounts's Intercept Pharmaceuticals, Inc. position peaked at $417K in Q3 2017.
- 168 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2017.
Based on FNY Managed Accounts's 13F filing for Q4 2017, filed 23 Jan 2018.